SGMT
SGMT
US7867001049
Sagimet Biosciences Inc. - Seri
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
633.21M EUR
477.58M EUR
170.26M EUR
192.53M EUR
Enterprise Value
316.27M EUR
313.63M EUR
133.67M EUR
157.58M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.87x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.15x
1.86x
1.66x
1.73x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.39%
-8.74%
-23.33%
-16.16%
ende